- Home
- / Gene Techno Science
Gene Techno Science
Stock Price
¥114
2024-10-29
Market Capitalization
¥4.5 B
2024-10-29
Revenue
¥5.1 B
FY, 2025
Gene Techno Science Summary
Company Summary
- Overview
- Gene Techno Science is a developer of drugs for cancer and other rare and intractable diseases. It focuses on the development of antibody drugs among the molecular targeted medicine.
- Type
- Public
- Status
- Active
- Founded
- 2001
- HQ
- Chuo City, JP | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Chuo City, Tōkyō-to HQ
Japan
1-chōme-2-12 Shinkawa
Gene Techno Science Financials
Summary Financials
- Revenue (Q3, 2026)
- ¥5.0B
- Gross profit (Q3, 2026)
- ¥1.3B
- Net income (Q3, 2026)
- (¥142.8M)
- Cash (Q3, 2026)
- ¥3.8B
- EBIT (Q3, 2026)
- ¥97.1M
- Enterprise value
- $3.3B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026